October 12, 2020
The CoVIg-19 Plasma Alliance, led by Takeda Pharmaceutical and CSL Behring, has launched a multinational PIII clinical study of the investigational anti-coronavirus hyperimmune intravenous immunoglobulin (H-Ig). Takeda Pharmaceutical said on October 9 that the first patient has been enrolled in...read more